Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and cisplatin followed by carboplatin and radiation in stage IV head and neck cancer
NCT00982436Phase 2Unknown
- Sponsor
- The University of Vermont
- Start
- Sep 2009
- Primary completion
- Sep 2012
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of docetaxel and Cisplatin micelle injection (HA132) in head and neck squamous cell carcinoma (HNSCC), sponsored by The University of Vermont. Status: unknown.
02
Drugs
docetaxelCisplatin micelle injection (HA132)
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT00982436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00982436.